Experts discuss the rapid evolution of chatbots, their impact on humanity, and the future of psychotherapy in a transformative technological era.
Michel Radomisli, PhD
Advertisement
Articles by Michel Radomisli, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves ProlivRX: First Prescription, Physician-Directed, At-Home Brain Neuromodulation Therapy for MDD
2
What Makes It So Special? A Review of the Mechanisms of Action of Lamotrigine, Carbamazepine, and Valproic Acid and How They Differ From Other Antiepileptics
3
New Useful Insights: Analysis of Data From Phase 3 Clinical Trials Evaluating Simufilam for Mild-to-Moderate Alzheimer Disease
4
Anticholinergic Burden and Its Effect on Cognition in Psychosis
5